ERBB2 and breast cancer: There is a rich literature investigating the immune response in TNBC and HER2 + breast cancer following NAC, demonstrating the correlation between immune infiltration and disease outcomes [47, 48] with respect to distant disease failure, which has not to our knowledge been reported with respect to LRR.